Delivery Order SPE2DB22D2206-SPE2DB24FFW55
Award Date
3/1/24
Potential Completion Date
3/4/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract, valued at $3,983.27, is for the provision of RESTASIS 0.05% eye emulsion to support DLA Troop Support Medical facilities and military treatment programs. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company AmerisourceBergen Corporation. The $11,364.34 contract is for the supply of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. The delivery order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $43,433.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Restasis 0.05% eye emulsion, a prescription medication, and has a completion date of May 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion. The $2,171.34 order has a completion date of February 26, 2024. As a prime contractor, Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,384.77 order is for the provision of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a completion date of February 28, 2024. This delivery order falls under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $8,806.64, is for the supply of RESTASIS 0.05% eye emulsion. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $40,943.16 to Amerisourcebergen Drug Corp, the prime contractor, for the provision of RESTASIS 0.05% eye emulsion. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $46,862.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This contract is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of June 9, 2022. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of RESTASIS 0.05% eye emulsion. The contract, valued at $4,425.80, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $11,816.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of Restasis 0.05% eye emulsion 60s to a location in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...